News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BeneChill Hires CEO, Alan Raffensperger



6/8/2010 7:26:52 AM

Xconomy -- Alan Raffensperger, an Amgen executive director who led the biotech’s nephrology franchise, has been named as the new CEO at San Diego-based BeneChill, according to a report today in Venture Wire. BeneChill, which Xconomy’s Denise Gellene profiled in December, is getting ready to launch its portable RhinoChill device in Europe. The device is used to lower the temperature of the brain and reduce the risk of brain damage, in heart attack patients.

Read at Xconomy


comments powered by Disqus
Xconomy
BeneChill
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES